Infographic: Why new incentives are needed to develop antibiotics

Ten million people are expected to die from infections caused by resistant bacteria by 2050 globally. Already there are 25,000 deaths in the EU alone every year. 

As of May 2017, 51 antibiotics and 11 biologicals were in the clinical pipeline. Only 5 are expected to reach the market.